NCT00453687View on ClinicalTrials.gov

A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK233705 In Healthy Volunteers.

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

March 9, 2007

Primary Completion Date

May 16, 2007

Study Completion Date

May 16, 2007

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

GSK233705

investigational drug

Trial Locations (1)

21225

GSK Investigational Site, Baltimore

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY